Timothy Moran
Chairman at MOTUS GI HOLDINGS, INC.
Net worth: 40 $ as of 2024-04-29
Profile
Timothy P.
Moran is currently the President & Chief Executive Officer at Avertix Medical Systems, Inc. and the Chairman at Motus GI Holdings, Inc. Previously, he served as the President-Americas at Convatec Group Plc from 2015 to 2018 and as the Vice President, GM-SharpSafety & Monitoring at Coviden Plc from 2010 to 2015.
Mr. Moran obtained his undergraduate degree from the State University of New York College at Geneseo.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
MOTUS GI HOLDINGS, INC.
0.01% | 2024-03-04 | 494 ( 0.01% ) | 40 $ | 2024-04-29 |
Timothy Moran active positions
Companies | Position | Start |
---|---|---|
MOTUS GI HOLDINGS, INC. | Chairman | 2023-04-12 |
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical DistributorsDistribution Services Avertix Medical Systems, Inc. develops and markets cardiac medical devices. Its product allows to reduce time to treatment and minimize heart muscle damage The company was founded by Robert E. Fischell, Tim A. Fischell and David R. Fischell in 2001 and is headquartered in Shrewsbury, NJ. | Chief Executive Officer | 2023-04-26 |
Former positions of Timothy Moran
Companies | Position | End |
---|---|---|
CONVATEC GROUP PLC | Corporate Officer/Principal | 2018-08-31 |
Coviden Plc | Corporate Officer/Principal | - |
Training of Timothy Moran
State University of New York College at Geneseo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CONVATEC GROUP PLC | Health Technology |
MOTUS GI HOLDINGS, INC. | Health Technology |
Private companies | 2 |
---|---|
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical DistributorsDistribution Services Avertix Medical Systems, Inc. develops and markets cardiac medical devices. Its product allows to reduce time to treatment and minimize heart muscle damage The company was founded by Robert E. Fischell, Tim A. Fischell and David R. Fischell in 2001 and is headquartered in Shrewsbury, NJ. | Distribution Services |
Coviden Plc |
- Stock Market
- Insiders
- Timothy Moran